Cited by 20Neutrophil, Myeloperoxidase and Oxidative MechanismsInflammatory mediators and NSAID effectsProtein Kinase Regulation and GTPase Signaling

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index; none of the 35 sources its claims cite is checked for support yet.

RhoH/TTF Negatively Regulates Leukotriene Production in Neutrophils

Open access
Daryadel, Arezoo, Yousefi, Shida, Troi, David, Schmid, Inès, Schmidt-Mende, Jan, Mordasini, Carlo, Dahinden, Clemens A, Ziemiecki, Andrew, Simon, Hans-Uwe·2009·The Journal of Immunology

Abstract

Leukotriene B4 (LTB4) is an important proinflammatory lipid mediator generated by neutrophils upon activation. GM-CSF stimulation is known to enhance agonist-mediated LTB4 production of neutrophils within minutes, a process called “priming”. In this study, we demonstrate that GM-CSF also limits the production of LTB4 by neutrophils via a transcriptional mechanism at later time points. We identified hemopoietic-specific Ras homologous (RhoH)/translocation three four (TTF), which was induced following GM-CSF stimulation in neutrophils, as a key regulator in this process. Neutrophils derived from RhoH/TTF-deficient (Rhoh−/−) mice demonstrated increased LTB4 production upon activation compared with normal mouse neutrophils. Moreover, neutrophils from cystic fibrosis patients expressed enhanced levels of RhoH/TTF and generated less LTB4 upon activation compared with normal human neutrophils. Taken together, these data suggest that RhoH/TTF represents an inducible feedback inhibitor in neutrophils that is involved in the limitation of innate immune responses.

Overview

CoChat Summary

Written by AI from the paper’s full text.

TL;DR

GM-CSF induces RhoH/TTF in neutrophils, and this inducible protein acts as a negative feedback regulator that limits LTB4 production. RhoH/TTF-deficient mouse neutrophils produce more LTB4 under prolonged GM-CSF pretreatment, while cystic fibrosis patient neutrophils express more RhoH/TTF and generate less LTB4.

Key findings

  • GM-CSF rapidly induces RhoH/TTF in mature neutrophils: microarray screening of 12,599 genes found RhoH/TTF upregulated 23.43-fold after 7 h GM-CSF; RT-PCR showed no detectable RhoH/TTF mRNA in freshly isolated neutrophils, induction within 30 min, and maximal mRNA at 1 h. RhoH/TTF protein was detected at 21.3 kDa, elevated between 1 and 3 h, and maximal after 4–8 h; IL-8 and IFN-γ did not induce it.
  • RhoH/TTF is expressed under inflammatory conditions: blood neutrophils from cystic fibrosis patients had increased RhoH/TTF protein, and neutrophils in appendicitis and ulcerative colitis tissue expressed RhoH/TTF in cytosol and at the cell membrane.
  • LTB4 production was reduced in cystic fibrosis neutrophils: normal neutrophils primed with GM-CSF and stimulated with C5a produced mean LTB4 levels >10,000 pg/ml (n = 10), whereas cystic fibrosis neutrophils produced <400 pg/ml (n = 6; p < 0.001).
  • RhoH/TTF deficiency increased LTB4 under prolonged pretreatment: wild-type and Rhoh−/− mouse neutrophils produced similar LTB4 after GM-CSF priming and C5a stimulation (mean ~15,000 pg/ml), but after GM-CSF pretreatment and IL-3 priming followed by C5a, Rhoh−/− neutrophils generated significantly more LTB4 than wild-type at 3, 5, and 8 h.

Methods

  • Human neutrophils were isolated from healthy donors and cystic fibrosis patients; mouse neutrophils were isolated from wild-type and Rhoh−/− C57BL/6J bone marrow. Purity was >95% for human and >90% for mouse neutrophils.
  • The study used microarray gene expression profiling (HG-U95Av2), RT-PCR, quantitative real-time PCR, immunoblotting, confocal microscopy, and LTB4 ELISA. Signaling inhibitors and cycloheximide were used to test pathways and protein synthesis dependence.
  • LTB4 production was measured after priming with GM-CSF or IL-3 for 30 min and subsequent C5a stimulation for 30 min; mouse experiments also used GM-CSF pretreatment for 3, 5, and 8 h. Statistical analysis used ANOVA followed by Tukey’s HSD test, with p < 0.05 considered significant.

Limitations

  • The paper states that how RhoH/TTF exerts its regulatory role in neutrophils remains to be investigated, and that the molecular mechanisms of RhoH/TTF gene transcriptional activation, intracellular movement, binding partners, exact signaling mechanisms, and possible additional cellular functions remain to be investigated.
  • The text makes evident that mechanistic studies in human neutrophils are limited because plasmid transfection appeared impossible and neutrophils are fragile and undergo rapid spontaneous apoptosis; the functional evidence therefore relies heavily on RhoH/TTF-deficient mouse neutrophils and cycloheximide treatment.
  • Some supporting data are described as “data not shown,” and the cystic fibrosis LTB4 experiments used small groups (n = 6 for LTB4; n = 3 for immunoblot), which limits generalizability.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.4049/jimmunol.0803846

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

49 Own result · 22 Not checked yet · 12 Own method · 12 Own interpretation

  • It may state two separate claims as one. 28
  • Probably not a substantial claim. 31
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Create a free account to see these assumptions.

44 more claims

Create a free account to see all 95 claims and to verify the 35 references still open.

See all claims — free account

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 43 references

Cited by

See all 20

Metadata

Authors
Daryadel, A., Yousefi, S., Troi, D., Schmid, I., Schmidt-Mende, J., Mordasini, C., Dahinden, C. A., Ziemiecki, A., & Simon, H.-U.
Affiliations
  • Institute of Pharmacology
  • Tiefenau Hospital Bern , Bern
  • Institute of Immunology
  • University of Bern (CH)
Corresponding author
  • Daryadel, Arezoo
  • Troi, David
Venue
The Journal of Immunology
Published
2009-05
Volume
182
Issue
10
Pages
6527-6532
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W1895469914
Cited by
20
References
43
Citations by year
2024: 3 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 2 · 2016: 1 · 2015: 1 · 2012: 2
FWCI
1.10
Type
journal article
Language
en
Open access
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • BORIS (University Library Bern) (submittedVersion)
Funders
  • National Science Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (107526, 112078)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords
leukotriene B4, neutrophils, GM-CSF, leukotriene biosynthesis, transcriptional regulation, cystic fibrosis, innate immune regulation, product inhibition
MeSH terms
Animals, Cystic Fibrosis, Enzyme-Linked Immunosorbent Assay, Gene Expression Regulation, Humans, Leukotriene B4, Neutrophils, Transcription Factors, Blotting, Western, Granulocyte-Macrophage Colony-Stimulating Factor, Mice, Knockout, Microscopy, Confocal, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, rho GTP-Binding Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review